Pharmaceutical & Nutraceutical Dust Collection
Your facility runs under FDA, cGMP, ISO 14644, and NFPA 660 simultaneously. Your dust collection system has to satisfy all of them — and hold up under inspection. Here’s how we design systems that do.
Your pharmaceutical or nutraceutical facility has the most demanding dust collection requirements of any manufacturing environment. It’s not just about worker protection — it’s about product protection, cross-contamination prevention, potent compound containment, and maintaining the validated cleanroom conditions that FDA and cGMP regulations require. A dust collection system in a pharma environment isn’t just equipment; it’s part of your quality system.
The challenges are compound-specific. Active pharmaceutical ingredients (APIs) range from relatively benign to highly potent with occupational exposure limits (OELs) below 1 μg/m³. Some are combustible. Many require containment to prevent cross-contamination between products on shared equipment. FDA 21 CFR Part 211 requires that dust collection systems be designed to prevent contamination — and every system must be documented, validated (IQ/OQ), and maintained under your quality management program.
If you’re comparing equipment options, start with our guide to the best dust collectors for pharmaceutical manufacturing — it walks through system types by application, from excipient handling to OEB 3+ contained filter change. For budgeting, our 2026 dust collection cost guide covers the premium pharma-grade systems carry for GMP construction and IQ/OQ documentation, so you can scope your project correctly upfront.
Every system we install is backed by our pass-or-free compliance guarantee and includes full IQ/OQ documentation packages for your validation files.
What Makes Pharma Dust Collection Different From Every Other Industry
Your dust collection system has to satisfy quality, containment, explosion protection, and cleanroom requirements at the same time. Here’s where facilities run into trouble.
Cross-Contamination Prevention
Multi-product facilities manufacturing different APIs, different dosage forms, or products with allergen concerns (penicillin, beta-lactams) on shared equipment must prevent cross-contamination between products. Dust collection systems are a critical engineering control — dedicated collectors per product or process area, proper air pressure cascades between rooms, and validated cleaning procedures for changeover all factor in. FDA inspectors specifically examine this during cGMP audits.
Potent Compound Containment
Highly potent APIs (HPAPIs) with occupational exposure limits below 10 μg/m³ — and some below 1 μg/m³ — require engineered containment far beyond standard dust collection. Containment booths, isolators, split-butterfly valves, and continuous liner systems prevent operator exposure during weighing, dispensing, charging, and discharging. The containment strategy is driven by the compound’s OEL/OEB classification.
Combustible Pharmaceutical Dust
Many pharmaceutical and nutraceutical powders are combustible — lactose, starch, sugar, cellulose, and numerous API powders have confirmed KSt values. NFPA 660 combustible dust requirements apply alongside cGMP requirements. Your system must satisfy both explosion protection requirements and pharmaceutical cleanliness and containment requirements — which sometimes create conflicting design constraints that require careful engineering.
Cleanroom Classification
Your manufacturing areas must meet specific ISO 14644-1 classifications — ISO 5 for aseptic filling, ISO 7 for many solid dosage operations, ISO 8 for support areas. HEPA and ULPA filtration in the air handling system maintains these classifications. Dust collection systems operating within classified spaces must not compromise the cleanroom environment — return air from collectors must be HEPA-filtered if recirculated into classified areas.
Validation & Documentation
Every dust collection system in your facility must be validated. Installation qualification (IQ) verifies the system was installed per design specifications. Operational qualification (OQ) verifies it operates within defined parameters. These documents become part of your validation master file and are reviewed during FDA inspections. Systems must also be included in your preventive maintenance program, calibration schedule, and change control process.
Product Recovery & Yield
Active pharmaceutical ingredients are expensive — some APIs cost thousands of dollars per kilogram. Dust that escapes during processing represents direct product loss. Properly designed dust collection captures this material and, depending on your process, can return it to the product stream (if validated for re-introduction) or prevent it from contaminating other areas. System design balances maximum capture efficiency with containment and cleanability requirements.
GMP Dust Collection Systems for Your Facility
Different operations require different levels of containment and filtration. Your process determines the system — not the other way around.
Pharmaceutical-Grade Dust Collectors
GMP-grade cartridge dust collectors built for pharmaceutical environments — stainless steel or epoxy-coated construction, smooth interior surfaces for cleanability, sanitary connections, HEPA safe-change (bag-in/bag-out) filter housings for contained filter replacement, and validated cleaning procedures for product changeover. Dedicated collectors for each process area or product line to prevent cross-contamination. Not sure which configuration fits your process? Our pharmaceutical dust collector guide compares the options by application.
Containment Booths & Isolators
Downflow containment booths provide a controlled-airflow environment for your weighing, dispensing, and sampling operations. HEPA-filtered downflow air sweeps powder away from the operator’s breathing zone. For highly potent compounds (OEL <1 μg/m³), rigid barrier isolators with glove ports provide the highest level of containment. Both are validated to specific containment performance levels through surrogate testing.
Cleanroom HEPA/ULPA Systems
HEPA (99.97% at 0.3 μm) and ULPA (99.995% at 0.12 μm) filtration systems for your classified manufacturing areas. Ceiling-mounted HEPA terminal housings, fan filter units (FFUs), and ducted HEPA systems sized to maintain ISO 14644-1 classifications. Individually scan-tested filters with DOP/PAO aerosol challenge certification. Filter integrity testing per ISO 14644-3 for ongoing validation.
Tablet Press & Coater Extraction
Dedicated dust extraction for your rotary tablet presses, tablet coaters, and capsule filling machines. Source capture at the press turret, tablet discharge, and deduster. Dust from tablet compression is the product itself — the collector must be designed for contained dust handling, product recovery where validated, and easy changeover cleaning between products. HEPA exhaust filtration prevents product dust from contaminating adjacent areas.
Blending & Granulation Extraction
Dust capture during your V-blender, ribbon blender, and high-shear granulator charging and discharging operations. Opening and closing blender access ports, dumping IBCs, and transferring granulate all release powder. Source-capture hoods, contained transfer connections, and local exhaust at loading and unloading positions minimize operator exposure and room contamination.
GMP Portable HEPA Vacuum
GMP-grade portable HEPA vacuum systems for your changeover cleaning between products, housekeeping in classified areas, and spill response. Stainless steel construction, HEPA-filtered exhaust, and anti-static design for combustible powder environments. These units are part of your cleaning validation program — documented, calibrated, and maintained under your quality system.
Where Does Your Facility Generate Dust?
Every operation has a different dust profile, containment requirement, and collection strategy. Here’s how we approach each one.
Weighing & Dispensing
Raw material weighing, API dispensing, and excipient portioning in dispensing booths. Downflow HEPA-filtered containment protects your operator and prevents cross-contamination. Contained weighing for potent compounds with validated containment performance levels.
Blending & Granulation
V-blenders, ribbon blenders, bin blenders, high-shear granulators, and fluid bed processors. Your dust generation peaks during charging, discharging, and transfer. Local exhaust and contained transfer connections at each loading and unloading point. Dedicated collection per blending suite prevents cross-contamination.
Tablet Compression
Rotary tablet presses generate continuous dust from the compression cycle. Turret extraction, discharge extraction, and deduster collection. Tablet press dust collectors are typically dedicated per press to prevent any cross-contamination between products.
Capsule Filling
Automatic and semi-automatic capsule filling machines generate powder dust during filling, tamping, and closing operations. Source capture at the fill station and capsule polisher. System design accounts for your specific powder characteristics — flow properties, moisture sensitivity, and potency.
Coating & Drying
Film coating pans, fluid bed dryers, and spray dryers generate dust and solvent vapors. Exhaust filtration captures coating dust; activated carbon handles solvent vapors where present. Temperature and humidity control in the exhaust stream affects filter performance and media selection for your process.
API Production
API synthesis, crystallization, drying, milling, and micronization. Your API production handles the most potent materials in the facility — containment requirements are driven by the compound’s OEL classification. Milling and micronization generate fine, respirable dust that requires high-efficiency filtration and may also be combustible.
Packaging Lines
Bottle filling, blister packaging, sachet filling, and powder fill operations. Your packaging areas must maintain cleanliness levels appropriate for the product while managing the dust generated during filling and sealing. De-nesting and container handling also generate particles that need capture.
Nutraceutical & Supplement
Dietary supplement manufacturing — blending, encapsulation, tablet pressing, and powder packaging for vitamins, minerals, herbal extracts, and protein powders. Many nutraceutical powders are combustible (lactose, starch, cellulose). FDA’s 21 CFR 111 framework applies similar dust control principles to the pharmaceutical framework.
What Your Regulatory Framework Requires
Your dust collection system has to satisfy multiple frameworks simultaneously. Here’s what each one actually requires — and where they create conflicting design constraints.
FDA 21 CFR Part 211 (cGMP)
Your dust collection systems fall under Subpart D (Equipment) — they must be of appropriate design, adequate size, and suitably located. Your air handling systems must prevent cross-contamination between manufacturing areas. All equipment must be documented, maintained on a preventive maintenance schedule, and included in your quality management system. IQ/OQ documentation is expected for validation compliance.
ISO 14644-1 Cleanroom Classification
Your manufacturing areas need specific ISO classifications: ISO 5 for aseptic filling, ISO 7 for many solid dosage operations, ISO 8 for general support areas. HEPA/ULPA filtration maintains your classifications. Initial and periodic particle count testing per ISO 14644-2 and -3 verifies your ongoing compliance.
NFPA 660 — Combustible Pharmaceutical Dust
Many pharmaceutical and nutraceutical powders are combustible — lactose, microcrystalline cellulose, starch, sugar, and numerous API powders. NFPA 660 (effective January 2026) requires a dust hazard analysis (DHA) and engineered explosion protection on your dust collection systems. The design challenge: satisfying both NFPA explosion protection requirements and your pharmaceutical cleanability and containment requirements at the same time. See our explosion protection assessment process for how we handle this.
ISPE & OEL/OEB Classification
ISPE guidelines provide frameworks for your containment strategy based on occupational exposure limits (OELs) or occupational exposure bands (OEBs). Compounds classified as OEB 4 or 5 (OEL <10 μg/m³ or <1 μg/m³) require high-containment engineering controls — isolators, contained transfer, and validated containment performance. Your compound’s OEB classification drives the dust collection and air handling design for each manufacturing area.
When a GMP Dust Collection System May Not Be What You Need
GMP-grade pharmaceutical dust collection is significantly more expensive than standard industrial equipment — stainless steel construction, HEPA safe-change housings, IQ/OQ documentation, and sanitary design add cost. That investment is justified for FDA-regulated manufacturing. It isn’t always the right call.
You may not need a full GMP system if your facility handles only non-potent, non-combustible nutraceuticals with no FDA drug approval, operates as a small R&D or pilot scale operation not subject to 21 CFR 211, or is an over-the-counter supplement manufacturer not seeking cGMP certification. In those cases, a well-designed standard industrial system with appropriate filtration may serve your dust control and worker safety needs without the GMP premium — our food and supplement manufacturing page covers that side of the line.
When we assess your facility, we’ll tell you honestly which requirements actually apply — and where standard equipment meets the need. Our cost guide breaks down the premium for GMP construction so you can evaluate the tradeoff before we start engineering.
Your Questions, Answered
Related Resources
Ready to Design Your GMP Dust Collection System?
Tell us about your facility — what you manufacture, what compounds you handle, your cleanroom classifications, and where your dust control concerns are. We’ll assess your operation, identify the containment and collection requirements for each process area, and design a system that holds up under FDA audit.
Serving pharmaceutical manufacturers across Arizona, California, Nevada, New Mexico, and Utah.